Significant pathways [18/95] pathways contains significant subpathways MAPK signaling pathway (hsa04010)
Chemokine signaling pathway (hsa04062)
Oocyte meiosis (hsa04114)
Wnt signaling pathway (hsa04310)
Axon guidance (hsa04360)
Focal adhesion (hsa04510)
Jak-STAT signaling pathway (hsa04630)
Natural killer cell mediated cytotoxicity (hsa04650)
T cell receptor signaling pathway (hsa04660)
Fc epsilon RI signaling pathway (hsa04664)
Regulation of actin cytoskeleton (hsa04810)
GnRH signaling pathway (hsa04912)
Pathways in cancer (hsa05200)
Colorectal cancer (hsa05210)
Glioma (hsa05214)
Prostate cancer (hsa05215)
Chronic myeloid leukemia (hsa05220)
Acute myeloid leukemia (hsa05221)
Drug repurposing [?]
None
Drugbank (The triangular compound term that is associated
with greater than or equal to genes)
Drugbank w/ drug-likeness (The triangular compound term that is associated
with greater than or equal to genes)
PharmGKB (The triangular drug term that is associated
with greater than or equal to genes)
PharmGKB w/ drug-likeness (The triangular drug term that is associated
with greater than or equal to genes)
Diseases (HGMD) (The triangular disease term that is
associated with greater than or equal to genes)
All rights reserved to BIBS laboratory, Seoul National University, Korea. |